Abstract
Objective: Epidemiologic studies suggest that subjects with elevated plasma concentrations of IGF-I are at increased risk of developing cancer. The objective of our study was to assess whether cancer risk factors such as lack of physical activity, obesity, and central body fat distribution are associated with plasma levels of IGF-I and related proteins (i.e. IGF binding proteins 1–3 and C-peptide). Methods: A cross-sectional study was conducted in a population of 225 premenopausal women, aged 49–57, participating in the Prospect–EPIC study in the Netherlands. Plasma concentrations of IGF-I, IGFBP-1, IGFBP-2, IGFBP-3, and C-peptide were determined. On the day of blood collection height, weight, and waist and hip circumference were measured. Habitual physical activity was assessed using a validated self-administered questionnaire. Results: Mean concentrations of plasma IGF-I, IGFBP-1, IGFBP-2, IGFBP-3, and C-peptide were 156.1, 14.3, 434.4, 3062, and 2.86 ng/ml, respectively. Women in the highest tertile for physical activity had lower plasma concentrations of IGF-I, IGFBP-3, and C-peptide, and higher concentrations of IGFBP-1 and IGFBP-2, as compared to women in the lowest tertile. However, these differences were not statistically significant. BMI and related measures were significantly inversely associated with IGFBP-1 and IGFBP-2, and positively with IGFBP-3 and C-peptide. Linear regression analyses showed that the non-significant association of physical activity with components of the plasma IGF system was further attenuated by adjusting for obesity and central body fat distribution. Conclusions: Our data suggest that an active lifestyle is not independently associated with the plasma IGF system. We did confirm that a lean body shape is associated with higher concentrations of IGFBP-1 and IGFBP-2, and possibly also with lower concentrations of IGF-I and IGFBP-3.
Similar content being viewed by others
References
Bruning PF, van Doorn J, Bonfrer JMG, et al. (1995) Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer. Int J Cancer 62: 266-270.
Chan JM, Stampfer MJ, Giovannucci E, et al. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566.
Ma J, Pollak MN, Giovannucci E, et al. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 91: 620-625.
Hankinson SE, Willett WC, Colditz GA, et al. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396.
Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS (1998) Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ or the breast. Epidemiology 9: 570-573.
Wolk A, Mantzoros CS, Andersson S-O, et al. (1998) Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90: 911-915.
Giacosa A, Francheschi S, LaVecchia C, Favero A, Andreatta R (1999) Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev 8(Suppl. 1): S53-S60.
Giovannucci E, Pollak MN, Platz EA, et al. (2000) A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9: 345-349.
Kaaks R, Toniolo P, Akhmedkhanov A, et al. (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92: 1592-1600.
Stattin P, Bylund A, Rinaldi S, et al. (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92: 1910-1917.
Toniolo P, Bruning PF, Akhmedkhanov A, et al. (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88: 828-832.
Hunter DJ, Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15: 110-132.
McTiernan A, Ulrich C, Slate S, Potter J (1998) Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control 9: 487-509.
Verloop J, Rookus MA, van der Kooy K, van Leeuwen FE (2000) Physical activity and breast cancer risk in women aged 20–54 years. J Natl Cancer Inst 92: 128-135.
Underwood LE (1996) Nutritional regulation of IGF-I and IGFBPs. J Pediatr Endocrinol Metab 9: 303-312.
Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92: 1472-1489.
Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocrine Rev 21: 215-244.
Collett-Solberg PF, Cohen P (2000) Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 12: 121-136.
Mårin P, Kvist H, Lindstedt G, Sjostrom L, Bjorntorp P (1993) Low concentrations of insulin-like growth factor-I in abdominal obestiy. Int J Obesity 17: 83-89.
Nam SY, Lee EJ, Kim KR, et al. (1997) Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obesity 21: 355-359.
Frystyk J, Skacrback C, Vestbo E, Fisker S, Orskov H (1999) Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 15: 314-322.
Riboli E (1992) Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol 10: 783-791.
Keinan Boker L, Noord van PAH, Schouw van der YT, et al. (2001) Prospect-EPIC Utrecht: study design and characteristics of the cohort population. (Submitted).
Pols MA, Peeters PH, Ocke MC, Slimani N, Bueno de Mesquita HB, Collette HJ (1997) Estimation of reproducibility and relative validity of the questions included in the EPIC physical activity questionnaire. Int J Epidemiol 26: s181-s189.
Voorrips LE, Ravelli ACJ, Dongelmans PCA, Deurenberg P, Staveren van WA (1991) A physical activity questionnaire for the elderly. Med Sci Sports Exerc 23: 974-979.
Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and IGF-I. Proc Nutr Soc 60: 91-106.
Goodman-Gruen D, Barrett-Connor E (1997) Epidemiology of insulin-like growth factor-I in elderly men and women: the Rancho Bernardo Study. Am J Epidemiol 145: 970-976.
Harrela M, Koistinen H, Kaprio J, et al. (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98: 2612-2615.
Hong Y, Pedersen NL, Brismar K, Hall K, de Faire U (1996) Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-I, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81: 1791-1797.
Eliakim A, Brasel JA, Mohan S, Barstow TJ, Berman N, Cooper DM (1996) Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females. J Clin Endocrinol Metab 81: 3986-3992.
Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM (1996) Acute effect of brief low-and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its protcolysis in young healthy men. J Clin Endocrinol Metab 81: 3492-3497.
Roelen CA, Vries de WR, Koppeschaar HP, Vervoorn C, Thijssen JH, Blankenstein MA (1997) Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training. Int J Sports Med 18: 238-241.
Eliakim A, Brasel JA, Mohan S, Wong WLT, Cooper DM (1998) Increased physical activity and the growth hormone-IGF-I axis in adolescent males. Am J Physiol 275: R308-R314.
Bonnefoy M, Kostka T, Patricot MC, Berthouze SE, Mathian B, Lacour JR (1999) Influence of acute and chronic exercise on insulin-like growth factor-I in healthy active elderly men and women. Aging 11: 373-379.
Chadan SG, Dill RP, Vanderhoek K, Parkhouse WS (1999) Influence of physical activity on plasma insulin-like growth factor-1 and insulin-like growth factor binding proteins in healthy older women. Mech Ageing Dev 109: 21-34.
Bermon S, Ferrari P, Bernard P, Altare S, Dolisi C (1999) Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiol Scand 165: 51-56.
Elias AN, Pandian MR, Wang L, Suarez E, James N, Wilson AF (2000) Leptin and IGF-I levels in unconditioned male volunteers after short-term exercise. Psychneuroendocrinology 25: 453-461.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Voskuil, D.W., Bueno de Mesquita, H.B., Kaaks, R. et al. Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1–3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control 12, 951–958 (2001). https://doi.org/10.1023/A:1013708627664
Issue Date:
DOI: https://doi.org/10.1023/A:1013708627664